Crowell & Moring Adds Leading Corporate Partner Jonathan Lisle in London

Crowell & Moring is pleased to announce the addition of Jonathan Lisle as a partner and new head of the firm’s London Corporate Practice. Lisle joins the firm from DLA Piper. His practice focuses on general private M&A across all sectors, and he also has particular experience in health care. He was the EMA head of health care at DLA Piper and was the co-founder of CMS Cameron McKenna’s health care group. Lisle brings extensive experience in cross-border mergers and acquisitions and further expands the firm’s international capabilities.

Lisle has acted on corporate transactions with deal values up to £10 billion (the largest being a bid for British Energy plc). His clients have included GE Capital (including the sale of the TIP Trailer business across 16 jurisdictions), GE Healthcare, Fidelity, Lebara Mobile, Senior plc, Renova Group, TIP Trailers, HNA Group, John Laing plc (on its £1 billion takeover by Henderson), ITE Group plc, Takeda Pharmaceuticals, Royal Bank of Scotland plc, HSBC, VT Group plc, National Australia Bank, and Survitec Group. He has advised on over 30 health care transactions, including for General Healthcare Group, Spire Healthcare, Ramsay Health Care UK, Nuffield Health, The Priory Group, LGV Capital, and Sovereign Capital.

“We are delighted to welcome Jonathan to our team. He will play an important role in many of our transatlantic deals and will help grow key client relationships in the health care arena, which is undergoing dynamic change at present,” said James R. Stuart III, chair of the firm’s Corporate Group. “As a leading corporate lawyer, his appointment will help bolster the London office and our European network.”

Lisle said, “I am proud to join such a well-respected group which boasts strong Corporate and Health Care practices. I’m also looking forward to broadening the capabilities of the London office and helping clients with their European, Middle Eastern and U.K. work—especially as U.S. and Australian health care companies continue to move across borders. We are well-placed to handle these matters.”

Source:  www.crowell.com